Anywhere from 2 million to 15 million people use kratom each year. While the substance does induce feelings of mild euphoria, ...

THE FOOD and Drugs Authority (FDA) has announced the initiation of an investigation into a recent report by BBC Africa Eye, ...

Northwell Health partnered with Stacker to analyze federal resources and news articles to illustrate how health crisis ...

ROCKAWAY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Sparrow Ascent by Spark Biomedi ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the ...

SB161 would require that non-opioid pain treatments that have FDA approval be included on this preferred drug list with coverage terms that are no more restrictive than those given to opioid pain ...

Health care providers can now administer Sublocade subcutaneously into the thigh, buttock, or the back of the upper arm, in addition to the abdomen.

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...